GO
Loading...

Biotech Hazards

Wednesday, 27 Dec 2006 | 1:13 PM ET

Examining the potential pitfalls of investing in biotech stocks in light of the Telik's failed late-stage trials, with Mike Huckman, CNBC Pharmaceuticals Reporter